2018
DOI: 10.3390/molecules23092301
|View full text |Cite
|
Sign up to set email alerts
|

Response of Cisplatin Resistant Skov-3 Cells to [Pt(O,O′-Acac)(γ-Acac)(DMS)] Treatment Revealed by a Metabolomic 1H-NMR Study

Abstract: The novel [Pt(O,O′-acac)(γ-acac)(DMS)], Ptac2S, Pt(II) complex has recently gained increasing attention as a potential anticancer agent for its pharmacological activity shown in different tumor cell lines, studied both in vitro and in vivo. The mechanism of action of Ptac2S, operating on non-genomic targets, is known to be very different from that of cis-[PtCl2(NH3)2], cisplatin, targeting nucleic acids. In this work, we evaluated the cytotoxicity of Ptac2S on the cisplatin resistant Epithelial Ovarian Carcino… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
36
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(42 citation statements)
references
References 78 publications
2
36
0
Order By: Relevance
“…Indeed, it is reported to be associated with chemoresistance to platinum salts, which is one of the main treatments for ovarian cancer [10]. Myo-inositol and phosphocholine (ChoP) have been reported in SKOV3 cells and their cellular concentrations reduced after treatment of Ptac2S, a novel anticancer agent [11]. Glutamate was found to be higher in SKOV3 and RCC cells compared with other cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, it is reported to be associated with chemoresistance to platinum salts, which is one of the main treatments for ovarian cancer [10]. Myo-inositol and phosphocholine (ChoP) have been reported in SKOV3 cells and their cellular concentrations reduced after treatment of Ptac2S, a novel anticancer agent [11]. Glutamate was found to be higher in SKOV3 and RCC cells compared with other cell lines.…”
Section: Discussionmentioning
confidence: 99%
“…For a better understanding of metabolic pathways which can have a significant impact on a given biological process after C8 or C10 addition to U87MG cells, we performed two types of pathway analyses. Metabolite Set Enrichment Analysis, performed using the Small Molecule Pathway Database and Metabolic Pathway Analysis, performed using the KEGG database, which also calculates the impact of each pathway using topology analysis in addition to the classic Enrichment Analysis (Girelli et al, 2016;De Castro et al, 2018). According to both p-value and impact value, the analysis showed target pathways that could be potentially altered following C8 or C10 addition to U87MG cells.…”
Section: Metabolic Pathway and Metabolite Set Enrichment Analysesmentioning
confidence: 99%
“…For example, De Castro et al [ 145 ] studied Ptac2S and its related cytotoxicity to the cisplatin-resistant epithelial ovarian carcinoma (EOC), Skov-3 cells. In the study, they used NMR spectroscopy and multi-variate statistical analysis to observe how Skov-3 cells reacted to treatment with Ptac2S.…”
Section: An Introduction To Nmr Spectroscopymentioning
confidence: 99%
“…The authors also noticed an unexpected difference in lipid metabolite expression levels between the cells treated with Ptac2S and those treated with cisplatin. These results provide a possible explanation for how Ptac2S is able to overcome cisplatin resistance in Skov-3 cells [ 145 ].…”
Section: An Introduction To Nmr Spectroscopymentioning
confidence: 99%
See 1 more Smart Citation